Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Trials of antivirals in t… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Trials of antivirals in the treatment of multiple sclerosis

Forskningsöversiktsartikel
Författare Jan Lycke
Publicerad i Acta Neurologica Scandinavica
Volym 136
Sidor 45-48
ISSN 0001-6314
Publiceringsår 2017
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap
Sidor 45-48
Språk en
Länkar doi.org/10.1111/ane.12839
Ämnesord acyclovir, antiviral treatment, herpes virus, human endogenous retrovirus, multiple sclerosis, trial, progressive multifocal leukoencephalopathy, central-nervous-system, cerebrospinal-fluid analysis, disease-modifying therapies, virus-antibody levels, risk stratification, pml risk, bk virus, natalizumab, viremia, Neurosciences & Neurology
Ämneskategorier Neurovetenskaper

Sammanfattning

There is increasing evidence that human herpes viruses and human endogenous retroviruses ( HERV) are involved in the aetiology and pathogenesis of multiple sclerosis ( MS). In order to acquire the ultimate evidence to confirm such a relationship, it is probably required to use specific antiviral drugs in clinical trials of MS. The results of published antiviral clinical trials in patients with MS are summarized in this review. None of them showed statistically significant effects on primary outcomes of disease activity or on disability development. However, given their small sample sizes, the strong trends and effects observed in subgroup analysis of antiherpes virus treatment in patients with MS warrant further studies. The possible involvement of HERV in MS is intriguing, and drugs have been developed that could reduce the impact of HERV in MS. However, larger studies are needed as the phase I and II trials were not designed to show clinical efficacy in MS.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?